Steven A. Gould
Amministratore Delegato presso Helus, Inc.
Profilo
Steven A.
Gould is currently the Chief Executive Officer & Director at Helus, Inc. and the Director at Innovation Development Institute, Inc. He was previously the Chairman & Chief Executive Officer at Northfield Laboratories, Inc. from 1993 to 2009 and an Operating Partner at Abundant Venture Partners LLC from 2016 to 2019.
Gould received his doctorate degree from Boston University in 1973 and his undergraduate degree from Williams College in 1968.
Posizioni attive di Steven A. Gould
Società | Posizione | Inizio |
---|---|---|
Innovation Development Institute, Inc.
Innovation Development Institute, Inc. Electronic Equipment/InstrumentsElectronic Technology Innovation Development Institute, Inc. operates as a community of healthcare innovators who aspire to heroic change. The company is headquartered in Chicago, IL. | Direttore/Membro del Consiglio | 01/01/2013 |
Helus, Inc.
Helus, Inc. Internet Software/ServicesTechnology Services Helus, Inc. offers secure communication, content exchange, electronic commerce and clinical workflow for community-based physician practices. The company is headquartered in Chicago, IL. | Amministratore Delegato | - |
Precedenti posizioni note di Steven A. Gould
Società | Posizione | Fine |
---|---|---|
Abundant Venture Partners LLC
Abundant Venture Partners LLC Investment ManagersFinance Abundant Venture Partners LLC (Abundant Venture Partners) is a venture capital firm founded in 2011 by Andrew Swinand and Eric Langshur. The firm is headquartered in Chicago, Illinois. | Investitore di Private Equity | 31/12/2019 |
Northfield Laboratories, Inc.
Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage. | Presidente | 10/11/2009 |
Formazione di Steven A. Gould
Boston University | Doctorate Degree |
Williams College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
Northfield Laboratories, Inc.
Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage. | Health Technology |
Innovation Development Institute, Inc.
Innovation Development Institute, Inc. Electronic Equipment/InstrumentsElectronic Technology Innovation Development Institute, Inc. operates as a community of healthcare innovators who aspire to heroic change. The company is headquartered in Chicago, IL. | Electronic Technology |
Helus, Inc.
Helus, Inc. Internet Software/ServicesTechnology Services Helus, Inc. offers secure communication, content exchange, electronic commerce and clinical workflow for community-based physician practices. The company is headquartered in Chicago, IL. | Technology Services |
Abundant Venture Partners LLC
Abundant Venture Partners LLC Investment ManagersFinance Abundant Venture Partners LLC (Abundant Venture Partners) is a venture capital firm founded in 2011 by Andrew Swinand and Eric Langshur. The firm is headquartered in Chicago, Illinois. | Finance |
- Borsa valori
- Insiders
- Steven A. Gould